SLV313 (1-(2,3-Dihydro-Benzo[1,4]Dioxin-5-Yl)-4- [5-(4-Fluoro-Phenyl)-Pyridin-3-Ylmethyl]-Piperazine Monohydrochloride): A Novel Dopamine D2 Receptor Antagonist and 5-Ht1a Receptor Agonist Potential Antipsychotic Drug
Neuropsychopharmacology - United Kingdom
doi 10.1038/sj.npp.1301098
Full Text
Open PDFAbstract
Available in full text
Date
May 17, 2006
Authors
Publisher
Springer Science and Business Media LLC